Corridor Pharmaceuticals, Inc. — Form D
Corridor Pharmaceuticals, Inc. of Baltimore, MD, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-24. The offering totals $14.5M, of which $13.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-06-24
- Form: D
- Accession: 0001471665-10-000002
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $14.5M
- Amount sold: $13.0M
- Remaining: $1.5M
- Investors: 8
- Date of first sale: 2010-06-11
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-143991
Issuer
- Name: Corridor Pharmaceuticals, Inc.
- CIK: 0001471665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1122 Kenilworth Drive, Baltimore, MD, 21204
- Phone: 410,616,0916
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Philip Patrick Goelet | Director | Lutherville, MD |
| Gary Lessing | Director | Owings Mills, MD |
| Stephen Roth | Director | Monmouth Junction, NJ |
| Zev Patrick Scherl | Director | Lutherville, MD |
| Geeta Patrick Vemuri | Director | Lutherville, MD |
| Philippe Patrick Walker | Director | Lutherville, MD |
| Gary Lessing | Executive Officer | Owings Mills, MD |
| Stephen Roth | Executive Officer | Monmouth Junction, NJ |
| Peter Suzdak | Executive Officer | Lutherville, MD |
| David Zopf | Executive Officer | Lutherville, MD |
| Geeta Vemuri | Director | Waltham, MA |
| Philip Goelet | Director | Lutherville, MD |
| Leonard Patrick Gage | Director | Baltimore, MD |
| Peter Patrick Greenleaf | Director | Baltimore, MD |
| David Patrick King | Director | Baltimore, MD |
| Brian Patrick Halak | Director | Baltimore, MD |
| Anne Patrick Shiflett | Executive Officer | Baltimore, MD |
| Mark Strobeck | Director | Baltimore, MD |
| Mark Strobeck | Executive Officer | Baltimore, MD |
| Phillipe Walker | Director | Lutherville, MD |
Other filings by this issuer (2)
More